Page last updated: 2024-09-04

ampelopsin and sofosbuvir

ampelopsin has been researched along with sofosbuvir in 1 studies

Compound Research Comparison

Studies
(ampelopsin)
Trials
(ampelopsin)
Recent Studies (post-2010)
(ampelopsin)
Studies
(sofosbuvir)
Trials
(sofosbuvir)
Recent Studies (post-2010) (sofosbuvir)
37723432,1643182,064

Protein Interaction Comparison

ProteinTaxonomyampelopsin (IC50)sofosbuvir (IC50)
Cytochrome P450 3A4Homo sapiens (human)8.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bae, SK; Cho, Y; Choi, G; Heo, TH; Jang, H; Jeong, YJ; Jung, DH; Kim, B; Kim, GW; Kwon, HJ; Lee, C; Lee, M; Lee, S; Min, DH; Oh, JG; Oh, JW; Windisch, MP; Yoon, KD1

Other Studies

1 other study(ies) available for ampelopsin and sofosbuvir

ArticleYear
Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase.
    British journal of pharmacology, 2016, Volume: 173, Issue:1

    Topics: Animals; Benzofurans; Biological Products; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Flavonoids; Hepacivirus; Humans; Phenols; Protein Binding; Rats; Resveratrol; RNA Helicases; Sofosbuvir; Stilbenes; Tissue Distribution; Viral Nonstructural Proteins; Virus Replication

2016